Compugen Ltd (CGEN)

Apr 24, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 24, 2025

Apr 13, 2025

67,041 Shares in Compugen Ltd. (NASDAQ:CGEN) Acquired by Raymond James Financial Inc. - Defense World

Apr 13, 2025

Apr 13, 2025

Compugen (NASDAQ:CGEN) vs. Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Financial Review - Defense World

Apr 13, 2025

Apr 12, 2025

Commonwealth Equity Services LLC Takes Position in Compugen Ltd. (NASDAQ:CGEN) - Defense World

Apr 12, 2025

Apr 12, 2025

Compugen Ltd. Announces Appointment of Alberto Sessa as Chief Financial Officer - marketscreener.com

Apr 12, 2025

Apr 09, 2025

Compugen at Stifel Forum: Strategic Insights on Immunotherapy Pipeline By Investing.com - Investing.com South Africa

Apr 09, 2025

Apr 09, 2025

Compugen at Stifel Forum: Strategic Insights on Immunotherapy Pipeline - Investing.com Australia

Apr 09, 2025

Apr 09, 2025

Is There An Opportunity With Compugen Ltd.'s (NASDAQ:CGEN) 33% Undervaluation? - simplywall.st

Apr 09, 2025

Apr 07, 2025

Compugen at Needham Conference: Strategic Immuno-Oncology Insights - Investing.com Australia

Apr 07, 2025

Apr 07, 2025

Compugen at Needham Conference: Strategic Immuno-Oncology Insights By Investing.com - Investing.com India

Apr 07, 2025

Apr 05, 2025

Compugen stock touches 52-week low at $1.35 amid market challenges - Investing.com Canada

Apr 05, 2025

Apr 04, 2025

Compugen stock touches 52-week low at $1.35 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 03, 2025

BeiGene stock slips on trial discontinuation (ONC:NASDAQ) - Seeking Alpha

Apr 03, 2025

Apr 02, 2025

Compugen at AI Drug Discovery Conference: Strategic Partnerships Drive Progress - Investing.com

Apr 02, 2025

Mar 26, 2025

Cancer AI Breakthrough: Compugen Takes Center Stage at 3 Elite Healthcare Forums - Stock Titan

Mar 26, 2025

Mar 23, 2025

Compugen Ltd. (CGEN): Among the Penny Stocks With Huge Upside Potential According to Analysts - MSN

Mar 23, 2025

Mar 23, 2025

Compugen Ltd. (NASDAQ:CGEN) Shares Acquired by Connor Clark & Lunn Investment Management Ltd. - Defense World

Mar 23, 2025

Mar 21, 2025

Reviewing Aligos Therapeutics (NASDAQ:ALGS) and Compugen (NASDAQ:CGEN) - Armenian Reporter

Mar 21, 2025

Mar 12, 2025

Compugen at Leerink’s Global Healthcare Conference: Strategic Insights By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 11, 2025

Compugen at Leerink’s Global Healthcare Conference: Strategic Insights - Investing.com

Mar 11, 2025

Mar 10, 2025

Oppenheimer & Co. Inc. Raises Stock Position in Compugen Ltd. (NASDAQ:CGEN) - Defense World

Mar 10, 2025

Mar 09, 2025

Earnings call transcript: Compugen Q4 2024 reveals revenue decline By Investing.com - Investing.com Australia

Mar 09, 2025

Mar 07, 2025

Compugen Ltd. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 07, 2025

Compugen (NASDAQ:CGEN) Rating Lowered to Hold at StockNews.com - Defense World

Mar 07, 2025

Mar 05, 2025

Rodman & Renshaw maintains $4 price target on Compugen stock By Investing.com - Investing.com Australia

Mar 05, 2025

Mar 05, 2025

Compugen Ltd. (NASDAQ:CGEN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 05, 2025

Mar 05, 2025

Compugen Ltd (CGEN) Q4 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - GuruFocus.com

Mar 05, 2025

Mar 04, 2025

Compugen’s 2024 Results Highlight Clinical Progress and Financial Stability - TipRanks

Mar 04, 2025

Mar 04, 2025

Earnings call transcript: Compugen Q4 2024 reveals revenue decline - Investing.com India

Mar 04, 2025

Mar 04, 2025

Rodman & Renshaw maintains $4 price target on Compugen stock - Investing.com India

Mar 04, 2025

Mar 04, 2025

Compugen Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 04, 2025

Mar 04, 2025

Compugen (CGEN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance

Mar 04, 2025

Mar 04, 2025

Compugen: Q4 Earnings Snapshot - CTPost

Mar 04, 2025

Mar 04, 2025

Compugen earnings missed by $0.09, revenue fell short of estimates - Investing.com South Africa

Mar 04, 2025

Mar 04, 2025

Compugen Reports 2024 Financial Results and Clinical Progress - TipRanks

Mar 04, 2025

Mar 04, 2025

Compugen: Q4 Earnings Snapshot -March 04, 2025 at 07:23 am EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Compugen Reports Fourth Quarter and Full Year 2024 Results -March 04, 2025 at 07:13 am EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Compugen reports Q4 EPS (7c) vs. 11c last year - TipRanks

Mar 04, 2025

Mar 04, 2025

Earnings Flash (CGEN) COMPUGEN LTD. Posts Q4 Loss $-0.07 Per Share -March 04, 2025 at 07:08 am EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Earnings Flash (CW9) COMPUGEN LTD. Posts Q4 Revenue $1.5M - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

Earnings Flash (CGEN) COMPUGEN LTD. Posts Q4 Revenue $1.5M -March 04, 2025 at 07:09 am EST - Marketscreener.com

Mar 04, 2025

Mar 04, 2025

How Compugen's Cancer Immunotherapy Pipeline Is Advancing While Extending Cash Runway to 2027 - StockTitan

Mar 04, 2025

Mar 03, 2025

Cancer Immunotherapy Pioneer Compugen to Share Insights at Major Healthcare Conference - StockTitan

Mar 03, 2025

Mar 03, 2025

Compugen to Participate in a Fireside Chat at the 2025 Leerink Partners Global Healthcare Conference - Yahoo Finance

Mar 03, 2025